Menu
Your Cart

Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)

Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)
Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)
Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)
Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)
Secured Shopping
Best security features
Apostle MiniEnrich Carboxyl Beads for Purification (30mL) (AMPure XP alternative)

Next-generation purification, size selection, and long-read size selection.

The Apostle MiniEnrich Purification Beads is designed for purification and clean-up of DNA fragments from the contaminants in NGS and molecular biology workflows. It can be used on samples after DNA isolation, fragmentation, PCR amplification, cloning, library preparation, etc. With proprietary Apostle MiniEnrich technology, the kit is featured for its more efficient removal of contaminants and recovery of DNA fragments of interest than current market-leading products.

  • Novel magnetic nanoparticles structure and proprietary surface chemistry.
  • Compatible with current workflows.
  • Enhanced performance for specific removal of non-target fragments.
  • Significantly improved magnetic response for less pelleting time and less beads carry-over.
  • This product is an effective alternative to AMPure XP.  AMPure XP is a brand name owned by Beckman Coulter.  This product is not manufactured by Beckman Coulter.  

 

Configuration:  30 mL

Cat #: A190607-30


Documentation

Protocol: https://www.apostlebio.com/minienrich/Minienrich_Purification.pdf

More information

$185.00
2024年2月,美国MD Anderson癌症中心科学家团队领衔的一项新临床研究发表在Cell子刊 Cancer Cell (影响因子 50.3),建立了临床证据和方法,使用肿瘤cfDNA 甲基化分析可以有效区分小细胞肺癌(SCLC) 亚型,并用于指导SCLC 治疗方案。 在论著的方法学部分,Apostle MiniMax cfDNA 试剂盒被明确列在“关键商业试剂” (Critical commercial assays)表格中,作出自己应用的贡献。Apostle 艾铂图 MiniMax 游离核酸技术不断在国际上得到广泛的应用,迄今,已发表、被引用 Nature 子刊 4篇 ( Nature Medicine X 2, Nature Communications X 2), Science 子刊 1 篇, PNAS 1 篇,各种临床研究60余篇,作者单位来自60余国际领先的医学研究和临床单位。 祝贺此临床研究团队!期待Apostle 艾铂图技术更好地为人类做贡献。